左炔諾孕酮宮內(nèi)節(jié)育系統(tǒng)聯(lián)合屈螺酮炔雌醇片在子宮腺肌癥中的應(yīng)用

打開(kāi)文本圖片集

中圖分類(lèi)號(hào)：R725.6 文獻(xiàn)標(biāo)識(shí)碼：A文章編號(hào)：1006-1959（2025）13-0103-05

DOI：10.3969/j.issn.1006-1959.2025.13.019

Abstract：Oeisaoetreigttendiosot tabletsndenosisodsightaitsdagosdideosisatajortspitalfroJarytnld and allocated via random number table method into a control group （n=4O）and a study group n=40 ）.The control group was treated with drospirenone ethinylestradibesallndoadioelesaess groupel （E2）vasculardotelialowthctorVGtesndstruatio（doerialicsteimee menstrualvolume），andincidenceofadversereactions（eadache，nauseaandvomiting，menstrualdisorder）werecomparedbetweentheto groups.Results The total effective rate of treatment in the study group（ 95.00% ）washigher than thatin the control group（ 72.50% ），and the differencewasstatistically significant（ P<0.05 ）.Theovarianfunctionindexes（AMH，F(xiàn)SH，LH，E2）of thetwogroupsafter treatmentwerelowerthan thosebefoetddeEf lower，the differencewas statistically significant（ P<0.05） .ThelevelofVEGFin the two groupsafter treatment waslower than thatbefore treatment， andcomparedwitotroloutevelofVGFintdyotertreamnteeiencasatistalyant P< 0.05）.Thedoealstmordsaloeofoueataoe beforetreatmtpadiootdoeraleseods group were lowerafter treatment，and the diference was statistically significant（ P- <0.05）.The incidence of adverse reactions in the study group （2.50 % ）was higher than that in the control group（ 17.50% ），and the difference was statistically significant （P

Keywords：Levonorgestrel-releasing intrauterine system;Drospirenone ethinyl estradiol tablets;Adenomyosis

子宮腺肌癥（adenomyosis）屬于臨床較為常見(jiàn)的一種疾病，主要是指患者子宮腺體以及子宮內(nèi)膜間質(zhì)侵入子宮基層形成的彌漫性或局限性病變，好發(fā)于20＼～50歲的育齡期女性，臨床表現(xiàn)主要包括月經(jīng)增多、子宮增大以及痛經(jīng)等，嚴(yán)重時(shí)甚至導(dǎo)致不孕，影響患者的身心健康1。（剩余7477字）